Cargando…
Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development
Immunotherapy with checkpoint inhibitors (antibodies that target and block immune checkpoints in the tumor microenvironment) is included in the standard of care for patients with different types of malignancy, such as melanoma, renal cell and urothelial carcinoma, lung cancer etc. The introduction o...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073577/ https://www.ncbi.nlm.nih.gov/pubmed/35527781 http://dx.doi.org/10.3892/ol.2022.13310 |